Pitakteerabundit Thakerng, Fagenholz Peter J, Luckhurst Casey M, Albutt Katherine H, Zhang M Lisa, Mino-Kenudson Mari, Hernandez-Barco Yasmin G, Stabile Tessa B, Warshaw Andrew L, Lillemoe Keith D, Qadan Motaz, Fernandez-Del Castillo Carlos
Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA; Department of Surgery, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand. Electronic address: https://www.twitter.com/thakerngP.
Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Surgery. 2025 May;181:109038. doi: 10.1016/j.surg.2024.109038. Epub 2024 Dec 31.
Acute pancreatitis is an uncommon presentation of intraductal papillary mucinous neoplasm; however, it is considered a worrisome feature in current guidelines and can be an indication for surgery. There is controversy regarding its association with malignancy, and there is little information regarding the recurrence of pancreatitis after surgical resection.
We retrospectively reviewed patients who underwent resection for intraductal papillary mucinous neoplasm at a single institution between January 1990 and December 2023. Patients with and without acute pancreatitis as part of the clinical presentation were compared.
A total of 812 patients were reviewed. Of these, 156 patients (19.2%) had intraductal papillary mucinous neoplasms associated with acute pancreatitis, and in 92% of them pancreatitis was the symptom leading to the diagnosis. Half of the patients had a single episode of pancreatitis (n = 77, 49.4%), and 42 (26.9%) had had 3 or more episodes before diagnosis. Acute pancreatitis was significantly associated with high-grade dysplasia (odds ratio 2.07) but had a lower likelihood of invasive cancer (odds ratio 0.62). It was also significantly associated with main duct and mixed duct-type intraductal papillary mucinous neoplasm (odds ratio 1.97) and intestinal epithelial subtype (odds ratio 2.28). Median follow-up for all patients was 61 months, and the likelihood of recurrent pancreatitis after surgical resection was 9% (14 patients), whereas pancreatitis after resection in patients without prior history occurred in only 0.9% (6 patients, P < .001).
Almost 1 in 5 patients undergoing resection for intraductal papillary mucinous neoplasm have a history of acute pancreatitis and are twice as likely to have high-grade dysplasia, supporting its categorization as a worrisome feature. Recurrence of pancreatitis after resection was 9%.
急性胰腺炎是导管内乳头状黏液性肿瘤的一种不常见表现;然而,在当前指南中它被视为一个令人担忧的特征,并且可能是手术指征。关于其与恶性肿瘤的关联存在争议,且关于手术切除后胰腺炎复发的信息很少。
我们回顾性分析了1990年1月至2023年12月期间在单一机构接受导管内乳头状黏液性肿瘤切除术的患者。比较了有和没有急性胰腺炎作为临床表现一部分的患者。
共纳入812例患者进行回顾性分析。其中,156例患者(19.2%)的导管内乳头状黏液性肿瘤与急性胰腺炎相关,其中92%的患者胰腺炎是导致诊断的症状。一半的患者有单次胰腺炎发作(n = 77,49.4%),42例(26.9%)在诊断前有3次或更多次发作。急性胰腺炎与高级别异型增生显著相关(比值比2.07),但发生浸润性癌的可能性较低(比值比0.62)。它还与主胰管和混合型导管内乳头状黏液性肿瘤(比值比1.97)以及肠上皮亚型(比值比2.28)显著相关。所有患者的中位随访时间为61个月,手术切除后胰腺炎复发的可能性为9%(14例患者),而既往无胰腺炎病史的患者术后胰腺炎发生率仅为0.9%(6例患者,P <.001)。
近五分之一接受导管内乳头状黏液性肿瘤切除术的患者有急性胰腺炎病史,且发生高级别异型增生的可能性是常人的两倍,这支持将其归类为一个令人担忧的特征。切除术后胰腺炎的复发率为9%。